Mutations in the OCRL gene, which encodes a PtdIns(4,5)P 2 5-phosphatase, cause oculo cerebro renal Lowe syndrome, a rare X-linked syndrome characterized by congenital cataracts, psychomotor disability, and renal Fanconi syndrome due to the inability of kidney proximal tubule cells (PTCs) to reabsorb low-molecularweight proteins and solutes from the ultrafiltrate 1, 2 . The progression of kidney damage towards end-stage renal failure is a leading cause of death in patients affected by Lowe syndrome, a disease for which no therapy is currently available.
OCRL is a multidomain cytosolic protein that associates with diverse subcellular compartments including clathrin-coated vesicles, early endosomes, the trans-Golgi network (TGN), and the primary cilium 3 . The association of OCRL with membranes involves several interactors such as AP2, clathrin, Rab GTPases, APPL1 and Ses proteins 3 . OCRL has been shown to control endocytic recycling, endosome-to-Golgi transport, early endocytic and phagocytic steps, cytokinesis, and cilium formation 3, 4 . The loss of OCRL function leads to an accumulation of PtdIns(4,5)P 2 and to uncontrolled actin polymerization on clathrincoated vesicles and early endosomes 4, 5 . This imbalance in PtdIns(4,5)P 2 and actin dynamics impairs the endocytic trafficking of different classes of receptors, including the multiligand receptor megalin that is responsible for low-molecular-weight protein reabsorption at the proximal tubule 5 . While impaired megalin trafficking may explain some signs of the disease, such as low-molecularweight proteinuria 5 , many gaps remain in our understanding of the mechanisms linking OCRL mutations to the impairment of PTC function, to the progressive deterioration of kidney function, and to the neuropathological signs in Lowe syndrome 6, 7 . Here, by combining unbiased and targeted approaches, we describe an unanticipated role of OCRL at lysosomes where it is recruited in the course of a response that we find to occur at lysosomes on arrival of autophagic cargo.
RESULTS

OCRL depletion induces the upregulation of lysosomal genes and morphological alterations of lysosomes
We initially undertook an unbiased approach to uncover how cells respond to the loss of OCRL by analysing the changes in gene A R T I C L E S . (b) Gene set enrichment analysis of the data in a. Subcellular compartments, except lysosomes, were defined according to the Human Protein Atlas. Lysosomal genes were defined according to Lysoplex 50 and excluded from the other categories. P values were calculated as described in the Methods. labelled with an anti-GFP antibody. The white dashed lines indicate the outline of pronephric tubules (top panels). Scale bars, 5 µm. Block face scanning electron microscopy images of transverse sections through proximal pronephric tubules from 72 hpf WT or ocrl −/− embryos (bottom panels). Scale bars, 5 µm. Graphs show the morphometric analysis of LAMP1-positive structures in c (n = 81 (CTRL) and n = 126 (OCRL-KD) structures pooled from three independent experiments) and d (n = 102 (CTRL) and n = 84 (Lowe) structures pooled from three independent experiments). In e, the external circumference of each lysosomal compartment (electron-dense oval or spherical membrane-enclosed organelle) was manually traced in each section and the average calculated. n = 30 sections (WT); n = 30 sections (ocrl −/− ) (10 sections analysed for three kidneys per category). Data are presented as means ± standard deviation (s.d.) * * * P < 0.001, calculated by two-tailed Student's t-test.
expression caused by the depletion of OCRL in human PTCs, the cells that are primarily compromised in Lowe syndrome ( Supplementary  Fig. 1a -c and Supplementary Table 1) .
We found that one of the gene classes most significantly upregulated after OCRL depletion coded for lysosomal proteins (Fig. 1a,b and Supplementary Fig. 2a ). This upregulation was accompanied by the nuclear translocation of the transcription factor TFEB ( Supplementary Fig. 2b-d) , a master regulator of lysosomal biogenesis that is activated under conditions that require increased degradation efficiency or induce lysosomal dysfunction 8 . The activation of TFEB and the presence of morphologically abnormal lysosomes in OCRL-depleted cells, in PTCs from Lowe syndrome patients, and in a recently described zebrafish model of Lowe syndrome 9, 10 ( Fig. 1c-e ) led us to investigate the role of OCRL at lysosomes.
OCRL is recruited to lysosomes in response to autophagosome-lysosome fusion in an AP2-and clathrin-dependent manner As mentioned above, OCRL has been reported to associate with clathrin-coated pits, clathrin-coated vesicles, early endosomes, the TGN, and the primary cilium 3 . However, this distribution pattern apparently contrasts with the first reported localization of OCRL, which indicated that OCRL associates with lysosomes that were however loaded with sucrose 11 . We reasoned that this apparent discrepancy might be due to the different loading state of lysosomes and therefore analysed the distribution of OCRL under a condition that induces a lysosomal cargo load such as starvation, during which lysosomes receive autophagosomal cargoes. We confirmed that OCRL associates mainly with early endosomes and the TGN ( Supplementary Fig. 1b ) and only occasionally co-localizes with the lysosomal marker LAMP1 under steady-state conditions (Fig. 2a,b) . However, it massively translocates to lysosomes on induction of autophagy (Fig. 2a,b) . The observation that this translocation was diminished when the fusion of autophagosomes with lysosomes was inhibited by depleting key components of the tethering (VPS16) and fusion (STX17) machinery or interfering with microtubule dynamics (vinblastine treatment) [12] [13] [14] (Fig. 2a,b) indicated that the fusion of autophagosomes with lysosomes triggers the recruitment of OCRL to lysosomes and prompted us to look for other components and for the signalling pathways mediating this response.
We first explored the involvement of clathrin and AP2, two main recruiters of OCRL to cellular membranes 15, 16 , and found that mutations in the AP2-and/or clathrin-binding sites of OCRL impaired the translocation of OCRL to lysosomes 16 ( Fig. 2c) . Confirming the importance of these two binding sites, INPP5B, a PtdIns(4,5)P 2 5-phosphatase that is highly similar to OCRL but lacks both the AP2-and clathrin-interacting motifs 16 , is not recruited to lysosomes in response to the delivery of autophagic cargo (Fig. 2c) .
Autophagosome-lysosome fusion triggers an increase in lysosome PtdIns(4,5)P 2 and the recruitment of AP2 and clathrin to lysosomes Prompted by the observation that AP2 and clathrin were required for the association of OCRL with lysosomes in response to autophagosome-lysosome fusion, we followed their localization during the course of the autophagy process. AP2 and clathrin have been reported to associate with lysosomes 17 and to be required for lysosome reformation at the end of autophagy on mTOR signalling reactivation [17] [18] [19] . We found that AP2 and clathrin are in fact recruited to lysosomes early during the autophagy process at a stage when mTOR is still inactive, and in a manner that is concomitant with and dependent on the fusion of autophagosomes with lysosomes and a local increase in PtdIns(4,5)P 2 produced by PI(4)KIIIβ, a kinase that preserves lysosomal identity 20 , and the kinases PIP5K1α and β (Fig. 3a-c and Supplementary Fig. 3a, b) . To search for signalling pathways mediating the lysosomal response to autophagosome fusion, we first considered the lysosome-based mTOR signalling 21 . However, multiple lines of evidence indicated that the local increase in lysosomal PtdIns(4,5)P 2 and the recruitment of OCRL are not dependent on mTOR activation or inactivation: first, OCRL is more associated with lysosomes (as compared with steady state) under conditions in which mTOR is either silent or fully active ( Fig. 3b and Supplementary Fig. 3c) ; second, the overall time course of OCRL translocation to lysosomes does not parallel that of mTOR inactivation-reactivation during nutrient deprivationinduced autophagy followed by nutrient re-addition (Fig. 3b) ; third, it is not starvation (and thus mTOR inactivation) per se but the arrival of autophagosomal cargo to lysosomes that induces this response (Fig. 3c) ; fourth, OCRL translocation can be seen using agents that induce autophagy and inactivate mTOR (torin 1) or induce autophagy without affecting mTOR activity (Tat-Beclin 1) 22 ( Supplementary  Fig. 3d , e).
TLR9 mediates the lysosomal response to autophagosome fusion
We therefore considered the involvement of other endolysosomebased signalling pathways, such as members of the family of tolllike receptors (TLRs) that are present in immune as well as in non-immune cells (including kidney PTCs [23] [24] [25] ) and recognize both exogenous and endogenous macromolecules [26] [27] [28] . We depleted TLR family members that can signal from endolysosomes (that is, TLR3, TLR4, TLR7, TLR9) and found that the response to autophagosomelysosome fusion was blunted-in terms of PtdIns(4,5)P 2 generation, and AP2, clathrin and OCRL recruitment-by selectively depleting or pharmacologically inhibiting TLR9 (Fig. 4a-c) . TLR9 resides mainly in the endoplasmic reticulum (ER) at steady state (with only a small fraction of receptors present in the endolysosomal compartment) but on arrival of TLR9 ligands into lysosomes it translocates to lysosomes via mechanisms that are only partially understood and that involve COPII-dependent ER export, the chaperone UNC93B1, and the small GTPase ARF3 29, 30 . In line with the notion that TLR9 activation is accompanied by its translocation to lysosomes, we found that TLR9 translocates from the ER to lysosomes on autophagy induction ( Fig. 4d and Supplementary Fig. 4a ) in a fashion that is dependent on autophagosome-lysosome fusion and on the presence of the TLR9 chaperone UNC93B1 (Fig. 4d ).
TLR9 is activated by mitochondrial DNA released into lysosomes by autophagosomes
The ligands for TLR9 are unmethylated CpG motifs that are found in bacterial DNA and in mitochondrial DNA (mtDNA) 31 . Indeed, the activation of TLR9 in response to mitochondrial damage and increased autophagy has been reported recently in non-immune cells such as cardiomyocytes 32 and hepatocytes 33 . We thus hypothesized that the autophagic cargo that triggers the TLR9-mediated lysosomal response might be mtDNA released into lysosomes by autophagosomes. In support of our hypothesis, depleting mitochondrial DNA (by two independent means, Supplementary  Fig. 4b , c) or depleting DNaseII (the lysosomal DNase required for TLR9 activation 34 ) inhibited the lysosomal response ( Fig. 4e and Supplementary Fig. 4d ), while inducing mitophagy with FCCP (a mitochondrial uncoupler that induces mitochondrial damage [35] [36] [37] ) or activating TLR9 with synthetic agonists mimicking unmethylated Figure 3 Autophagosome-lysosome fusion induces a local increase in PtdIns(4,5)P 2 , and the recruitment of AP2 and clathrin to lysosomes. (a) Representative images and quantification of the recruitment of the indicated proteins and of lysosomal PtdIns(4,5)P 2 levels during starvationinduced autophagy in HK-2 cells. Cells were incubated in growth medium or in HBSS for 3 h, fixed and stained with an anti-LAMP1 antibody together with an anti-AP2, anti-clathrin or anti-PtdIns(4,5)P 2 antibody. Scale bars, 10 µm. Insets, enlargements of the outlined areas. Means ± s.d., n = 450 cells per condition pooled from six independent experiments. (b) Quantification of the arrival of autophagic cargo to lysosomes (LC3-LAMP1), of the level of lysosomal PtdIns(4,5)P 2 (assessed by anti-PtdIns(4,5)P 2 antibody staining, LAMP1-PtdIns(4,5)P 2 ), and of the recruitment of AP2 (LAMP1-AP2), clathrin (LAMP1-clathrin), and OCRL (LAMP1-OCRL) to lysosomes at 30, 60 and 180 min of HBSS treatment and 30 min and 180 min after complete medium re-addition (Refeeding). At the same time points, mTOR activity status was analysed (black dashed line) as the ratio of phospho-S6 kinase to total S6 kinase (a representative blot is reported in Supplementary Fig. 3c and an unprocessed original scan of the blot is shown in Supplementary  Fig. 9 ). Data are expressed as percentage of the maximum value. Mean values ± s.d. n = 450 cells per condition pooled from three independent experiments. (c) CTRL (mock-treated) cells and VPS16-KD cells (to impair autophagosome-lysosome fusion) were incubated in growth medium or in HBSS for 3 h, fixed and stained as above. The graph reports the percentage of total LAMP1 structures that were positive for PtdIns(4,5)P 2 , AP2 and clathrin. Means ± s.d. of n = 450 cells per condition pooled from three independent experiments. P values were calculated by one-way ANOVA with Tukey's post hoc test. Statistical source data can be found in Supplementary Table 2.
CpG motifs elicited the lysosomal response in terms of an increase in lysosomal PtdIns(4,5)P 2 and the recruitment of AP2, clathrin and OCRL (Fig. 4f) .
We investigated the signalling cascade triggered by the activation of TLR9 in response to mtDNA and found that known components of the TLR9 signalling and trafficking pathway-such as TIRAP, which also translocated to lysosomes ( Supplementary Fig. 4e ), MyD88, IRAK4 and UNC93B1-were involved ( Supplementary Fig. 4f ). We next asked how the activation of TLR9 could lead to the local increase in PtdIns(4,5)P 2 . Although a link between the activation of TLR and PtdIns(4,5)P 2 generation has been previously reported, the underlying mechanisms have remained unexplored so far 38 . We found that the activation of TLR9 is accompanied by and required for the translocation of PIP5Kα and β to lysosomes (Fig. 4g,h ) and that TLR9 belongs to a molecular complex containing also PIP5Kα, since the two proteins can be co-immunoprecipitated (Fig. 4i) .
The TLR9-mediated lysosomal cargo response sustains the autophagic flux Altogether, the above data unmasked a regulatory circuit in lysosomes that is activated by autophagic cargo and prompted us to ask what might be the purpose(s) of this circuit and what is the specific role of OCRL in it. We found that this circuit controls local (that is, lysosomal) and transcriptional responses. Locally, it is required for lysosomal homeostasis since lysosomes enlarge and accumulate internal membranes on depletion or inhibition of TLR9 (Fig. 5a,b ) and for efficient autophagic flux (Fig. 5c,d ) since the depletion or pharmacological inhibition of TLR9 led to the accumulation of autophagosomes (Fig. 5d ). This accumulation is accompanied by impaired autophagosome-lysosome fusion (as assessed by following the yellow-to-red conversion of the mRFP-GFP tandem-LC3 reporter 39 Fig. 5e ) possibly induced by defective recycling of the autophagic SNARE syntaxin17 14 from autolysosomes ( Supplementary Fig. 4g ). Concomitantly with this local lysosomal response, TLR9 stimulation by mtDNA triggers the canonical TLR9-dependent signalling cascade involving the activation and nuclear translocation of the transcription factor NF-κB and an increase in the transcription of proinflammatory cytokine and interferon beta genes (Fig. 5f,g ). This indicates that the mtDNA released into lysosomes during autophagy has the potential to trigger an inflammatory response. We envisage that this response is usually self-limiting due to the complete degradation of oligonucleotides containing unmethylated CpG motifs by lysosomal exonucleases, nucleotidases and phosphatases but might become sustained under conditions of prolonged stress and/or impaired degradative capacity, such as during lysosomal storage disorders, which, in fact, are often accompanied by chronic inflammation 40 .
OCRL controls the autophagy flux through its 5-phosphatase activity
We then explored the role of OCRL in the lysosomal cargo response and its relevance for the manifestations of Lowe syndrome. We found that OCRL-depleted cells have a higher number of mature An unprocessed original scan of the blot is shown in Supplementary  Fig. 9 . Parallel samples were analysed by LC-MS/MS and peptides significantly matching human OCRL (Q01968-2) were found in anti-MCOLN1 immunoprecipitates but not in control-IgG immunoprecipitates. P values were calculated by one-way ANOVA with Tukey's post hoc test. Statistical source data can be found in Supplementary Table 2 . Scale bars, 10 µm.
autophagosomes under normal growth conditions 41 ( Fig. 6a-c and Supplementary Fig. 5a ). This elevated number of autophagosomes is due to delayed basal autophagic flux through lysosomes as assessed by the increase in the autophagy substrate p62 42 ( Supplementary  Fig. 5b ). Although TFEB activation might in part contribute to the increase in basal p62 levels in OCRL-depleted cells, the inability of bafilomycin to induce a further increase in p62 levels indicates that this increase is mainly due to impaired autophagic flux to lysosomes, as also testified by the increase in LC3II protein levels ( Supplementary Fig. 5b ). The impaired autophagic flux is caused by an impairment of autophagosome-lysosome fusion as assessed by the lower co-localization of autophagosomal and lysosomal markers and the impaired yellow-to-red conversion of the tandem fluorescent-LC3 probe (Fig. 6d,e and Supplementary Fig. 5c, d ). Importantly, a striking accumulation of autophagosomes was also observed in proximal tubules from kidney biopsies of Lowe syndrome patients ( Fig. 6f and Supplementary Fig. 6a, b) highlighting the physiopathological relevance of the lysosomal role of OCRL, prompting us to clarify the molecular mechanisms underlying this role. These involve the catalytic activity of OCRL since YU142670, an OCRL inhibitor 43 , also Growth medium BafA1 SF-51 Supplementary Fig. 9 . The data in both graphs on the right are mean values ± s.d.; n = 6 lysates per condition pooled from six independent experiments. P values were calculated by Student's t-test. Statistical source data can be found in Supplementary Table 2. induced an accumulation of autophagosomes (Fig. 6a,b) while the autophagic flux could be restored by expressing wild-type (WT) but not catalytically inactive OCRL in OCRL-defective PTCs or in PTCs from Lowe syndrome patients (Fig. 6a,b,g ). Of note, we detected an excess of lysosomal PtdIns(4,5)P 2 in OCRL-depleted cells (Fig. 7a,b and Supplementary Fig. 5e , f) that could be rescued by re-expressing WT, but not catalytically inactive, OCRL ( Supplementary Fig. 5f ) or by lowering PtdIns(4,5)P 2 production through the depletion of PIP5K α or β (Fig. 7b) . Notably, these two independent PtdIns(4,5)P 2 -reducing approaches were both effective in rescuing the autophagy flux in OCRL-depleted cells (Figs 6a,b and 7c) , indicating that the excess lysosomal PtdIns(4,5)P 2 had a causative role in impairing autophagosome-lysosome fusion in OCRL-depleted cells.
OCRL is required to preserve the activity of MCOLN1
We searched for the target(s) of the inhibitory effect of PtdIns(4,5)P 2 on autophagosome-lysosome fusion. One interesting candidate was mucolipin-1 (MCOLN1, also referred as TRPML1), a lysosomal calcium channel required for lysosome fusion with autophagosomes whose activity is stimulated by PtdIns(3,5)P 2 but inhibited by PtdIns(4,5)P 2 (refs 44-46) . Indeed, we found that MCOLN1-dependent calcium release was compromised-that is, no response at low concentrations and slower response at high concentrations of MCOLN1 agonist-in OCRL-KD cells 47 as compared with control cells (Fig. 7d) . We also obtained independent lines of evidence indicating that MCOLN1 and OCRL interact: firstly, the overexpression of MCOLN1 recruits WT but not the AP2-defective binding mutant of OCRL to lysosomes (Fig. 7e) ; secondly, MCOLN1 is required for OCRL translocation to lysosomes (Fig. 7f) ; thirdly, the two proteins can be co-immunoprecipitated (Fig. 7g) . Thus, our results indicate that both MCOLN1 (Fig. 7f) and AP2 (Fig. 2c) are required for the lysosomal recruitment of OCRL, but that neither of them on its own is sufficient since AP2-defective OCRL mutants are no longer recruited to lysosomes even in cells overexpressing MCOLN1 (Fig. 7e) , and AP2-competent OCRL cannot be recruited to lysosomes in the absence of MCOLN1 (Fig. 7f) . This combined requirement indicates that a mechanism of coincidence detection drives and calibrates in time and space the recruitment of OCRL to lysosomes ensuring that OCRL is recruited to lysosomal regions/domains containing both MCOLN1 and AP2.
Boosting MCOLN1 activity rescues the autophagic flux in Lowe syndrome patient PTCs
Since OCRL depletion did not have an impact on MCOLN1 localization ( Supplementary Fig. 7a ), we concluded that the MCOLN1 dysfunction in OCRL-depleted cells was due to reduced activity caused by an excess of PtdIns(4,5)P 2 . Hence, we reasoned that boosting the activity of MCOLN1 in OCRL-depleted cells might rescue lysosomal function. To this end we used two independent approaches: the overexpression of MCOLN1 (the WT form and MCOLN1-3A, a mutant MCOLN1 unable to bind PtdIns(4,5)P 2 ; ref. 44) or the use of a MCOLN1 activator at a concentration that is effective in inducing lysosomal calcium release in OCRL-depleted cells (Fig. 7d) . We observed that both the overexpression of MCOLN1, more potently in its PtdIns(4,5)P 2 -insensitive form (MCOLN1-3A), and treatment with the MCOLN1 activator SF-51 (which we further characterized for its specificity, Supplementary Fig. 7b ) rescued the defects in autophagic flux in OCRL-depleted cells (Fig. 8a,b) . Importantly, the MCOLN1 activator also rescued the impaired autophagic flux in PTCs from Lowe syndrome patients (Fig. 8c,d ), thus indicating MCOLN1 as a possible drug target for the treatment of Lowe syndrome.
DISCUSSION
Here we have unveiled a heretofore unknown ability of lysosomes to sense the arrival of autophagic cargo and at the same time a pathophysiological pathway in Lowe syndrome ( Supplementary  Fig. 8 ). The mtDNA released by autophagosomes into lysosomes stimulates TLR9, which activates its known downstream effectors, such as the transcription factor NF-κB ( Supplementary Fig. 8 ), but also induces a local increase in PtdIns(4,5)P 2 . The observation that OCRL, a 5-phosphatase, is recruited almost simultaneously with PIP5Ks demonstrates the need for a strict spatial and temporal restriction of PtdIns(4,5)P 2 levels in lysosomes. The local increase in PtdIns(4,5)P 2 is needed for the recruitment of AP2 and clathrin. We envisage that AP2-mediated clathrin recruitment controls distinct budding events in lysosomes in distinct stages of autophagy. During ongoing autophagy (this report) it may mediate the recycling of components, such as syntaxin 17, needed to sustain an efficient autophagic flux, while at the end of autophagy, as shown in ref. 19 , it mediates autophagic lysosome reformation to regenerate primary lysosomes that have been consumed through their fusion with autophagosomes. PtdIns(4,5)P 2 , which is required for these budding events, has to be nevertheless restricted to limited domains in the lysosome since it can act as an endogenous inhibitor of the calcium channel MCOLN1 44, 48 . This is the task of OCRL, which interacts with MCOLN1 and which ensures PtdIns(4,5)P 2 -free microdomains around MCOLN1 (Supplementary Fig. 8) . Indeed, the uncontrolled increase in lysosomal PtdIns(4,5)P 2 that results from the loss of function of OCRL inhibits MCOLN1 activity and, consequently, the autophagic flux, inducing the accumulation of autophagosomes that is observed in cells and, notably, in the kidney of Lowe syndrome patients. The lysosome dysfunction and the impaired autophagic flux are bound to play a pivotal role in the progression of renal damage, a so far poorly understood process, and, possibly, also in the generation of central nervous systemrelated symptoms and of neuropathological signs in Lowe syndrome patients 6, 7, 49 . Finally, and most importantly, MCOLN1 emerges as an interesting drug target since MCOLN1 agonists are able to restore the autophagosomal flux in cells from Lowe syndrome patients.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. 
M E T H O D S METHODS
Antibodies, cDNAs and reagents. All chemical reagents were of analytical grade or higher and purchased from Sigma-Aldrich unless otherwise specified. The anti-OCRL, -PI(4)KIIIβ and -GST polyclonal antibodies have been described in ref. 5 . The other primary and secondary antibodies used in this study are listed in Supplementary Table 3 . Other reagents: Quant-iT PicoGreen, FuraRed, Hanks' balanced salt solution with calcium and magnesium (HBSS) 1×, Opti-MEM (Life Technologies); SF-51, YU142670 43 (STK001646 and STK883823, respectively) (Vitas-M Laboratory); agarose-linked anti-GFP antibody (Vector Laboratories); bafilomycin, vinblastine, FCCP, ethidium bromide, uridine, Protein A/G Sepharose (Sigma-Aldrich); sodium pyruvate (Euroclone); ODN 2216, ODN 2395, ODN TTAGGG (InvivoGen); Torin-1 (Tocris Bioscience); Tat-beclin 1 peptide, digitonin (Merck-Millipore). The GST-tagged PH domain of PLCδ was prepared as described previously 5 . Tandem fluorescent mRFP-eGFP-LC3 was provided by A. Fraldi (TIGEM, Pozzuoli, Italy). TLR9-YFP (plasmid no. 13642) and TIRAP-GFP (plasmid no. 52739) were from Addgene. The full-length WT and mutant form (V527D) of OCRL were described previously 5 . Mutations in the clathrin-binding domains (LIDIA, I74N and LIDLE, deltaLIDLE) and in the AP2-binding motif (FxDxF, F151S) of OCRL were generated using the QuikChange mutagenesis system (Agilent Technologies) following the manufacturer's protocol using the primers listed in Supplementary  Table 4 . The GFP-OCRL-X3 16 triple mutant was generated by sequential mutagenesis of LIDIA, LIDLE and FxDxF domains.
Full-length INPP5B (NM_005540) was obtained from HeLa cell cDNA using the primers reported in Supplementary Table 4 and cloned using the restriction sites SalI/SmaI into the pEGFP-C1 expression vector (Clontech).
Myc-DDK-MCOLN1 (NM_020533) was purchased from Origene Technologies. The MCOLN1[R42A;R43A;R44A] mutant (reported in the main text and figures as MCOLN1-3A) was generated using the primers reported in Supplementary Table 4 .
Cell culture, transfection and treatments. HK-2 cells were grown as previously described 5 . HK-2 cells were transiently transfected using TransIT-LT1 (Mirus Bio LLC), unless otherwise specified, according to the manufacturer's instructions, and incubated for 18-24 h before fixation. The HK-2 cell line was checked for mycoplasma contamination by a PCR-based method. The HK-2 cell line was not found in the database of cell lines that are currently known to be cross-contaminated or misidentified by ICLAC and NCBI Biosample. The cell lines used in this study were not authenticated. All cell-based experiments were repeated at least three times.
Proximal tubular cells from Lowe syndrome patients.
The procedure for proximal tubular cell (PTC) isolation and immortalization from the urine of control healthy subjects and from Lowe syndrome patients is reported in ref. 5 . PTCs were transfected using JetPEI (Polyplus transfection) according to the manufacturer's instructions. siRNA treatment. siRNA sequences used in this study are listed in Supplementary  Table 1 . siRNAs against TFEB, described in ref. 8 , were provided by C. Settembre (TIGEM, Pozzuoli, Italy).
HK-2 cells were transfected with siRNAs for 96 h using DharmaFECT 4 (Dharmacon) according to the manufacturer's instructions. The siRNA duplexes were used at 50 pmol for OCRL, TLRs, TIRAP, IRAK4, MyD88, DNaseII, UNC93B1 and TFAM and at 25 pmol for PIP5Ks, MCOLN1, VPS16, STX17, RAB7 and TFEB. Mock-treated or non-targeting siRNA-treated HK-2 cells are referred to as controls (CTRL). OCRL-KD was performed using a pool of two OCRL siRNAs from Sigma (N1, N5, used for all experiments unless otherwise stated) and a pool of three OCRL siRNAs from Ambion, described in the text as OCRL-KD (A). For mitochondrial gene expression analysis and for the evaluation of mtDNA depletion, qRT-PCR was performed as previously described 51 . The sequences of primers used in this study are listed in Supplementary Table 4 .
Microarray experiments. The Affymetrix Gene-Chip (HG-U113A) hybridization experiments were performed in triplicate at the Coriell Genotyping and Microarray Center, Coriell Institute for Medical Research, Camden, New Jersey, USA, on total RNA extracted from control and OCRL-depleted cells. To identify downstream transcriptional effects of OCRL-siRNA treatment, microarray data were preprocessed using the Bioconductor package Affy 52 and normalized with the RMA method 53 . Differentially expressed genes between conditions (KD versus control)
were identified using a Bayesian t-test 54 . For each P value, the Benjamini-Hochberg procedure was used to calculate the false discovery rate (FDR) to avoid the problem of multiple testing.
Gene set enrichment analysis was performed using the freely available software GSEA v2.0 from the Broad Institute 55 . The goal of GSEA is to determine whether members of a given gene set tend to occur toward the top (or bottom) of a ranked gene list. To run the GSEA algorithm, RMA-normalized microarray data were used. The GSEA algorithm collapsed the probe sets into gene symbols (∼13,300 genes) and ranked the genes in the OCRL-KD expression data set on the basis of the fold change after OCRL-KD. GSEA analysis for subcellular distribution was conducted using the Human Protein Atlas for all but lysosomal genes, which were defined according to Lysoplex 50 and excluded from the other categories. To evaluate the significance of the enrichment score the hypergeometric distribution was calculated that describes the probability of k successes in n draws (up-and downregulated genes for each enriched category).
CLEAR analysis.
We selected the genes corresponding to the top 250 upregulated probes in the OCRL-KD expression profile. The proximal promoter sequences (1,000 bp upstream and 200 downstream of the transcriptional start site) for each gene were obtained from the UCSC genome browser 55 and searched with the matchPWM function in the Bioconductor package Biostrings 56 for matches with the CLEAR motif 57 .
Mitochondrial DNA (mtDNA) depletion and visualization. Mitochondrial DNA depletion was achieved by siRNA knockdown of TFAM or by incubating HK-2 cells in complete medium with ethidium bromide (100 ng ml −1 ), uridine (50 mg ml −1 ) and sodium pyruvate (110 mg ml −1 ) for 4 days to reduce mtDNA levels. Evaluation of depletion was performed using Quant-iT PicoGreen and qRT-PCR as previously described 51, 58 .
Immunoprecipitation and western blot. HK-2 cells were plated in 150 mm plates until they reached 95% confluency. Cells were then washed three times with icecold 1× PBS, scraped, and proteins were extracted in ice-cold lysis buffer (25 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA and 1% NP-40 supplemented with phosphatase and protease inhibitor cocktails, Roche), centrifuged for 15 min at ×16,000g at 4 • C, and the supernatants were collected. Cell supernatants (1 mg) were incubated for 16 h at 4 • C with 1 µg of the appropriate antibody or with 15 µl of agarose-linked anti-GFP antibody (for TLR9-YFP immunoprecipitation). Samples were then incubated with Protein A/G Sepharose for 2 h at 4 • C (except for TLR9-YFP immunoprecipitation). Immunoprecipitates were collected by centrifugation at ×5,000g at 4 • C, washed five times in lysis buffer and twice in lysis buffer without NP-40 and the proteins were eluted with Laemmli sample buffer (60 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue) and denatured at 95 • C for 5 min. Samples were analysed by SDS-PAGE (8%) under reducing conditions and transferred to nitrocellulose. The membranes were then incubated with the appropriate antibodies. Enhanced chemiluminescence reagent (Euroclone) was used for protein detection. Western blot quantitative analysis (p62/β-actin and LC3/β-actin ratio and p-S6K/S6K ratio) was performed using ImageJ band analysis 59 .
Confocal fluorescence microscopy, super-resolution microscopy, image processing, and co-localization analysis. HK-2 cells and PTCs were grown to subconfluence on glass coverslips and immunofluorescence microscopy and quantitative image analysis were performed as described previously 5 , except for OCRL-LAMP1 co-labelling where a different permeabilization step was used (that is, 5 min with 20 µM digitonin in buffer A (20 mM PIPES pH 6.8, 137 mM NaCl, 2.7 mM KCl)). The experiments were repeated at least three times and representative images are shown. The level of co-localization (that is, LAMP1-OCRL, LAMP1-TLR9, LAMP1-TIRAP, LAMP1-LC3, LAMP1-AP2, LAMP1-clathrin, LAMP1-TLR9-YFP, LAMP1-TIRAP, LAMP1-PI(4)KIIIβ, LAMP1-PIP5K1α, LAMP1-PIP5K1β, LAMP1-PI(4,5)P 2 , MCOLN1-OCRL, MCOLN1-LAMP1) was calculated by acquiring confocal serial sections from about 50-100 cells per experimental condition per experiment, exported in TIFF format, and processed as previously described 5 . Briefly confocal images of at least 50-100 cells per condition were acquired at the same laser power and photomultiplier gain. Images were then processed using ImageJ software. Single channels from each image were converted into 8-bit greyscale images and thresholded to subtract background. The ImageJ ' Analyze Particles' plugin was then used to identify and count the total number of the structures (with an area above 0.10 µm 2 ) in channel 1 (that is, LAMP1). The structures in channel 2 (that is, OCRL) were used to build a mask that was then overlapped with the LAMP1 structures to subtract the structures containing both markers. The remaining structures, positive only for LAMP1, were counted and by difference the number of structures containing both LAMP1 and OCRL was calculated and expressed as a percentage of the total number of DOI: 10.1038/ncb3386 LAMP1-positive structures. Note that this quantitative analysis procedure does not use merged images and is not affected by the fluorescence intensity.
For conventional confocal microscopy a confocal laser microscope (Zeiss LSM 700 confocal microscope systems; Carl Zeiss) with a ×63 1.4 NA oil immersion objective was used. Super-resolution microscopy was performed with a Zeiss LSM 880 (Carl Zeiss), Airyscan-equipped confocal microscope with a ×63 1.4 NA oil immersion objective. After acquisition, images were processed with the Airyscan processing tool available on the Zen software provided by Zeiss, with a processing threshold set at 3.9.
PtdIns(4,5)P 2 detection. Control (mock) and OCRL-siRNA-treated HK-2 cells were grown to 70-80% density on glass coverslips and PtdIns(4,5)P 2 staining was performed according to ref. 60 . Briefly cells were fixed for 15 min at room temperature by addition of 1 volume of pre-warmed 4% PFA (paraformaldehyde in PBS) to the growth medium (2% PFA final concentration). Cells were then permeabilized for 5 min with 20 µM digitonin in buffer A. Cells were then blocked for 45-60 min with buffer A containing 5% FBS (fetal bovine serum) and 50 mM NH 4 Cl. Recombinant GST-PH-PLCδ (0.2 mg ml −1 ) or anti-PtdIns(4,5)P 2 antibody was added at this stage in buffer A for 90 min at room temperature. After three washes with buffer A, anti-GST (in the case of GST-PH-PLCδ) and anti-LAMP1 antibodies were applied for 1 h at room temperature. After three washes, secondary fluorophore-labelled antibodies were added. Cells were post-fixed for 5 min with 2% PFA, washed twice in 1× PBS containing 50 mM NH 4 Cl, washed once in milliQ water and analysed using a confocal laser microscope (Zeiss LSM 700 confocal microscope systems; Carl Zeiss) with a ×63 1.4 NA oil immersion objective. Quantitative analysis of PtdIns(4,5)P 2 -LAMP1 co-localization was performed as previously reported 5 .
Autophagy induction by Torin 1 and Tat-beclin 1 peptide. HK-2 cells were treated for 2 h with 250 nM of the specific mTOR inhibitor Torin 1 (Tocris Bioscience) added to complete growth medium. HK-2 cells were washed twice with PBS and once with Opti-MEM and then incubated for 2 h with 20 µM of the Tat-beclin 1 peptide 22 dissolved in acidified Opti-MEM (9 mM HCl).
Quantitative analysis of LC3 structures. CellProfiler, a free, open-source image analysis software (www.cellprofiler.org), was used for quantitative analysis of confocal microscopy images by applying specific pipelines described in ref. 61 . The pipeline 'Speckle Counting' was used to identify smaller objects (LC3-positive structures) surrounding larger objects (nuclei) and to perform per-object aggregate measurements (such as the number of LC3-positive structures per nucleus). Briefly, the images were converted to greyscale using the module 'ColorToGray' . Then the 'ObjectIdentification' module was used to identify nuclei (called primary objects) on the basis of Hoechst staining. Secondary objects (LC3-positive structures) were detected and counted using the module 'IdentifySecondaryObjects' by expanding the area surrounding the primary object by 20 pixels.
Human kidney biopsies. Human kidney biopsies were obtained from archived samples of three patients with clinical diagnosis of Lowe syndrome, corroborated in one case (shown in Fig. 6f ) with the genetic diagnosis of mutation in OCRL, two patients affected by glomerular (and not tubular) disease, and two controls (nontransplanted, normal human kidney). Informed consent was obtained and the use of the human biopsy samples was approved by the Ethical Review Board of SaintLuc Academic Hospital (Brussels, Belgium) and the EURenOmics consortium (FP7, 2007-2013, grant agreement no. 305608).
Immunofluorescence on human kidney samples. Paraffin blocks of human kidney samples were sectioned into consecutive slices with a thickness of 6 µm using a Leica RM2255 rotary microtome (Thermo-Fisher Scientific) on Superfrost Plus glass slides (12-550-15, Thermo-Fisher Scientific). Before staining, slides were deparaffinized in changes of CitriSolv (22-143-975, Thermo-Fisher Scientific,) and 70% isopropanol. Antigen retrieval was accomplished by incubating in sodium citrate buffer (1.8% 0.1 M citric acid, 8.2% 0.1 M sodium citrate, in distilled water, pH 6.0) in a rice cooker for 30 min. The slides were blocked with PBS blocking buffer (1% BSA, 0.2% non-fat dry milk in PBS) for 30 min and stained with primary antibodies specific for LC3B (Nanotools) or LAMP1 (Abcam) and AQP1 (Merck-Millipore) diluted in blocking buffer overnight at 4 • C. The anti-LC3B antibody recognizes both the soluble (LC3-I) and the membrane-bound form (LC3-II) of LC3B 62 . After two washes in 0.1% Tween 20 (v/v in PBS), the slides were incubated with the corresponding fluorophore-conjugated secondary antibodies (Life Technologies) diluted in blocking buffer at room temperature for 1 h and counterstained with 10 µM Hoechst 33342 (Life Technologies). The slides were subsequently mounted in Prolong Gold Anti-fade reagent (Life Technologies) and images were acquired on a Leica SP5 confocal laser scanning microscope (Center for Microscopy and Image Analysis, University of Zurich) equipped with a Leica APO 63× NA 1.4 oil immersion objective and then processed with Adobe Photoshop (Adobe System) software.
Quantitative image analysis was performed by random selection of ∼10 visual fields that included 5-6 proximal tubules that were scanned for each slide, using the same setting parameters (that is, pinhole, laser power, and offset gain and detector amplification below pixel saturation). The number of LC3-or LAMP1-positive structures per proximal tubule (AQP1-positive) was quantified by means of Quantitation Module of Volocity software (PerkinElmer Life Science, I40250).
Zebrafish strains and husbandry. Zebrafish were maintained at The University of Manchester Biological Services Unit in accordance with the policies of the UK Animal Act 1986. Wild-type adults and larvae were of the AB strain. The ocrl1 −/− mutant line (ZDB-GENO-120531-1) was previously described 9, 10 . The only procedure involving animals was the breeding of transgenics, which is subject to local ethical review and performed under a Home Office licence. No statistical method was used to predetermine sample size; the experiments were not randomized, and the Investigators were not blinded to allocation during experiments and outcome assessment. Experiments were performed on larvae at 3 days postfertilization, at which point they are not classified as animal experiments.
Electron microscopy. Cells for pre-embedding immunoelectron microscopy were fixed, permeabilized, and labelled as described previously 63 . From each sample, thin 65 nm sections were cut using a Leica EM UC7 ultramicrotome. EM images were acquired from thin sections using an FEI Tecnai-12 electron microscope (FEI) equipped with a VELETTA CCD (charge-coupled device) digital camera (Soft Imaging Systems GmbH). We used the following criteria for morphological identification: lysosomes (Ly): LAMP1-positive single-membrane-bound bodies containing electron-dense material; multivesicular bodies (MVB): LAMP1-positive single-membrane-bound bodies containing more than nine intralumenal vesicles; multilamellar bodies (MLB): LAMP1-positive single-membrane-bound bodies containing myelin-like figures; autophagic vacuoles (AV): double-membranebound vacuoles containing sequestered material (only cytoplasm, cytoplasm and/or ER, cytoplasm and/or mitochondria, ER and/or mitochondria); autolysosomes (AL): LAMP1-positive single-membrane-bound bodies containing electron-dense cytoplasmic material and/or organelles. The number of autophagosomes was then calculated using iTEM software (Olympus SYS). Zebrafish samples were processed for electron microscopy as described previously 9 .
Dissection of autophagosome-lysosome fusion by tandem fluorescent LC3. Control (mock), OCRL-and TLR9-siRNA-treated HK-2 cells were grown to 70% confluency and transiently transfected with a plasmid encoding an mRFP-GFPtagged LC3 39 . After transfection, cells were kept in growth medium for 16 h and then incubation was continued in normal growth medium or the cells were treated with HBSS for 3 h. CTRL cells were also treated for 3 h with 25 µM of OCRL inhibitor (YU142670) or 0.5 µM of TLR9 antagonist (ODN TTAGGG). Where reported, cells were also treated with protease inhibitor cocktail 39 (PI: leupeptin, E64D and pepstatin, Sigma-Aldrich) for the indicated time points. After fixation with 4% PFA, cells were washed three times with 1× PBS containing 50 mM NH 4 Cl, mounted and imaged using a Zeiss LSM 710 confocal microscope (equipped with a ×63 1.4 NA oil immersion objective).
Calcium measurements by confocal imaging using FuraRed. FuraRed-loaded cells were analysed according to the previously described protocol 64 . Briefly, mock HK-2 cells or OCRL-silenced HK-2 cells were loaded with 5 µM FuraRed-AM for 1 h at 37 • C in calcium imaging buffer. Pseudocolour ratiometric images (458 and 488 nm excitation, 610 nm emission) were collected using a Carl Zeiss microscope (LSM 710) equipped with a variable filter wheel. FuraRed ratios (emission at F 458 nm /F 488 nm) were used to represent changes in cytosolic Ca 2+ levels in basal conditions or after specific treatments. The number of cells that mobilized calcium was quantified in a minimum of three wells and compared with control cells transfected with scramble siRNAs. More than 20 cells in triplicate were used in the different experiments.
Statistics and reproducibility.
For experiments involving living animals no statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.
Immunofluorescence experiments were repeated independently three times and at least 50 cells were analysed from a single experiment. Representative images are shown in Figs 1c,d,e, 2a,c, 3a, 4b,d,g, 5a,d,e, 6a,d ,e,f,g, and 7a,e,f; and in Supplementary Figs 2b, 3b, d, 4b, d , e, g, 5a, c, e, f, 6a, b and 7a.
Western blotting and immunoprecipitation experiments were repeated at least three times and representative blots are shown in Figs 4i, 5c and 7g, and in Supplementary Figs 1a, 3a , 5b and 7c. Uncropped scans of the blots are shown in Supplementary Fig. 8 .
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Most data are presented as the means ± standard deviation (s.d.) unless otherwise specified. Statistical comparisons were made using Student's t-test when comparing two groups. One-way analysis of variance (ANOVA) with Tukey's post hoc test was performed for comparisons among more than two groups relative to a single factor (treatment or siRNA-induced knockdown). Two-way ANOVA and Tukey's post hoc test was performed for comparisons among more than two groups relative to two factors (treatment and siRNA-induced knockdown). These analyses were performed in the R (ref. 65) (http://www.R-project.org) environment. For all analyses, a P value <0.05 was considered to be statistically significant. For the quantification of LC3-and LAMP1-positive structures in kidney biopsies, ANOVA was also used. A P value <0.05 was considered to be statistically significant. The results of the statistical analysis, comprising the P values of the whole experimental data sets and the P values deriving from post hoc tests, are reported in Supplementary Table 2 .
Data availability. Microarray data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession code GSE54284. Source data for Figs 2b,c, 3a,c, 4a,c,e,f,h, 5b-g, 6b-e,g, 7b,c,e,f and 8b,c,d , and for Supplementary Figs 2b, 3a, b,e, 4e,f,g, 5a,f and 7b are available in Supplementary Data are means ± s.e.m., n=50 proximal tubules pooled from 10 fields per biopsy. *p < 0.0025 calculated calculated using one-way ANOVA/post-hoc tests. 
